Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Cash from Financing Activities (2016 - 2025)

Lipocine (LPCN) has disclosed Cash from Financing Activities for 13 consecutive years, with $141334.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities changed N/A year-over-year to $141334.0, compared with a TTM value of $358774.0 through Sep 2025, up 75.83%, and an annual FY2024 reading of $209340.0, down 48.26% over the prior year.
  • Cash from Financing Activities was $141334.0 for Q3 2025 at Lipocine, down from $217440.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $29.4 million in Q1 2021 and bottomed at -$1.5 million in Q2 2022.
  • Average Cash from Financing Activities over 5 years is $1.7 million, with a median of -$5900.0 recorded in 2022.
  • The sharpest move saw Cash from Financing Activities tumbled 118.41% in 2021, then soared 956904.55% in 2023.
  • Year by year, Cash from Financing Activities stood at -$838463.0 in 2021, then soared by 99.3% to -$5900.0 in 2022, then rose by 10.19% to -$5299.0 in 2023, then skyrocketed by 4203.42% to $217440.0 in 2024, then tumbled by 35.0% to $141334.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for LPCN at $141334.0 in Q3 2025, $217440.0 in Q2 2024, and -$8100.0 in Q1 2024.